March 3, 2015 by Mark Hollmer
OrthoSensor says it pulled in a $17 million funding round for its Verasense knee implant technology.
OrthoSensor said it pulled in a funding round worth nearly $17 million that it hopes will eventually add up to $19 million.
The Florida maker of knee implant placement technology disclosed the round in a recent regulatory filing.
OrthoSensor’s Verasense device is designed to help surgeons measure proper placement and motion during total knee replacement procedures.
OrthoSensor closed a $48 million Series B round in October 2013, just after its Verasense device gained a CE Mark approval in the European Union. The FDA granted 510(k) clearance to the VeraSense device in June 2013.